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Trends box 
Modifications in mRNA have been known for a long time to be present in animals, plants and 
viruses, and have now also been detected in bacterial and archeal mRNAs. Systematic analysis of 
their occurrence and functions, however, was hampered until recently by technical limitations to 
detect these modifications and by the lack of knowledge of the enzymes involved.  
 
Recent advances in high-throughput sequencing technology in combination with selective 
chemical and immunological identification of modified nucleotides is now revealing the global 
topology of many modifications in mRNA. 
 
N6-methylated adenosine (m6A) is one of the most abundant modifications in mRNA. Recent 
progress has shed light on its biological functions, adding a new layer of post-transcriptional 
gene regulation. 
 
 
 
Abstract  
Modifications in messenger RNA (mRNA) constitute ancient mechanisms to regulate gene 
expression post-transcriptionally. N6-methyladenosine (m6A) is the most prominent mRNA 
modification, which is installed by a large methyltransferase complex (the m6A ‘writer’), 
specifically bound by RNA binding proteins (the m6A ‘readers), but also removed by 
demethylases (the m6A ‘erasers’). m6A mRNA modifications have been linked to regulation at 
multiple steps in mRNA processing. In analogy to the regulation of gene expression by miRNAs, 
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we propose that the main function of m6A is post-transcriptional fine-tuning of gene expression. 
In contrast to miRNA regulation, which mostly reduces gene expression, we argue that m6A 
provides a fast mean to post-transcriptionally maximise gene expression. Additionally, m6A 
appears to have a second function during developmental transitions by targeting m6A-marked 
transcripts for degradation. 
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Ancient modifications in RNA 
Modified nucleotides were first discovered in transfer RNAs (tRNA) and ribosomal RNAs 
(rRNA), and these modifications are present in all organisms [1-4]. Some of the same nucleotide 
modifications were later identified in messenger RNAs (mRNA) of prokaryotes, eukaryotes and 
viruses, revealing an entire new layer of regulation of gene expression [5-8], which has been 
termed epitranscriptomics (Box 1) [9]. 
Recent technological advances in high-throughput sequencing in combination with 
antibody-enrichment and/or induced nucleotide-specific chemical modifications have accelerated 
the mapping of modifications both on abundant tRNAs and rRNAs and on the less abundant 
mRNAs [9-16]. A striking observation of these studies was the prevalence of few modifications 
in mRNA and their non-random distribution, implying important regulatory functions. 
Furthermore, they can be dynamic and exhibit changes in distribution or frequency in response to 
various stresses.  
N6-methyladenosine (m6A) is the most common internal modification in mRNA and long 
non-coding RNA [9, 12]. m6A profiling experiments in higher eukaryotes revealed its conserved 
enrichment near stop codons, long internal exons and, less commonly, start codons. In addition, 
m6A has also been found enriched in ribosome-associated mRNA [17-19]. Genetic loss-of-
function studies for m6A methyltransferases (m6A writers), m6A-binding proteins (m6A readers) 
and m6A demethylases (m6A erasers) (see Box 2 and Figure 1) have highlighted a critical role for 
the m6A modification in the control of gene expression in several physiological processes (for 
recent reviews see [6, 20]).  
However, it is still not clear precisely how m6A affects gene expression and what benefit 
cells and organisms obtain from this extra regulatory layer. A number of recent studies 
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characterizing the role of m6A in alternative splicing and translational regulation provide insights 
into the more general function of m6A in gene expression at the molecular level [17, 18, 19, 28, 
32, 41]. Based on these observations detailed and discussed below, we propose that a main 
function of m6A is to fine-tune gene expression.  
 
Functions of m6A in development, cellular differentiation and disease 
Insights into the function of m6A have come from recent RNAi knock-down and genetic knock-
out experiments in cell culture and model organisms. Mutants lacking m6A have been identified 
in several organisms including yeast, plants, flies and mice. In the yeast Saccharomyces 
cerevisiae, only meiotic mRNAs are m6A methylated and meiosis can only occur if cells posses 
the core subunit of the methyltransferase complex IME4 (Inducer of Meiosis-4, see Box 2) [21, 
22]. In the plant Arabidopsis and in mice, m6A is required for viability [23, 24]. Functions in 
mammals include roles in embryonic stem cell differentiation, maintaining circadian rhythms 
and dosage compensation (Box 3) [23, 25-30]. Recent studies in Drosophila revealed that m6A-
devoid flies are viable. However, they show reduced fertility and are flightless, and they also 
suffer from neurological, sex determination and dosage compensation defects (see below) [19, 
31, 32].  
Emerging evidence also suggests links between m6A modifications of mRNA and cell 
transformation and cancer. For instance, hypoxia promotes breast cancer progression in part by 
reducing m6A levels via increased expression of the demethylase ALKBH5 (See glossary) [33]. 
Likewise, m6A also plays roles in glioblastoma stem cell renewal and tumorigenesis [34, 35]. 
Furthermore, several components of the methyltransferase complex including METTL3, 
METTL14 and RBM15 are all highly expressed in myeloid leukemia compared with other 
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cancers, and their alterations are linked with poor prognosis, suggesting that elevated m6A levels 
might predispose to this cancer type [36, 37]. In addition, the m6A methyltransferase complex 
was shown to have an 8-15 fold higher activity upon cellular transformation [38]. 
 
m6A in meiosis, sex determination and dosage compensation: A unifying 
theme? 
m6A is involved in various aspects of sexual development in yeast, Drosophila and eutherian 
mammals. Although many different mechanisms have evolved for sexual differentiation, 
common elements such as Doublesex transcription factors have been identified in various 
organisms such as insects and mammals [39]. The role of m6A in meiosis in yeast, sex 
determination and dosage compensation in Drosophila as well as dosage compensation in 
eutherian mammals might indicate a central function for m6A in allowing for evolution of 
diverse sex determination mechanisms observed in nature.  
In S. cerevisiae, meiosis requires remodeling of the translatome, which includes positive 
selection by marking transcripts with m6A for translation [17]. In S. pombe, the YTH domain 
protein Mmi1 adopted a novel mode to binding RNA in the absence of m6A. MmiI then 
selectively removes meiotic transcripts during vegetative growth via the DSR element 
specifically present in meiotic transcripts [40, 41]. A role for m6A in meiosis in mice has been 
suggested, but such a role in Drosophila seems absent [19, 29, 32]. However, the function of 
m6A in yeast is reminiscent of the situation at the maternal-to-zygotic transition (MZT) shortly 
after fertilization, where the zygote removes maternal transcripts. In zebrafish, this is in part 
achieved by m6A marking of certain maternal transcripts for decay [42]. The same effect could 
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also be achieved by favoring translation of zygotic transcripts by analogy with favored 
translation of meiotic transcript in S. cerevisiae. 
In Drosophila and mammals, m6A has key roles in the regulation of dosage 
compensation, but by different mechanisms. In mammals, m6A enhances Xist function for X 
chromosome inactivation, while in Drosophila m6A enhances Sex lethal (Sxl) splicing to achieve 
maximal Sxl expression [19, 28, 32]. Sxl then suppresses dosage compensation in females by 
inhibiting translation of Male-specific lethal-2 (Msl-2), which is required for up-regulation of 
transcription from the single male X chromosome.  
C. elegans employs an unusual mechanism of dosage compensation, in which expression 
of both X chromosomes is down-regulated in hermaphrodites by about half, and this might offer 
a hint as to why it does not need m6A. Alternatively, loss of m6A could potentially be 
compensated by other mRNA modifications, or could be linked to trans-splicing prominently 
present in this organism [43]. When we finally understand how C. elegans can live without the 
m6A machinery, this may yield insights into the broader functional relevance of this 
modification. 
 
m6A can affect most aspects of gene expression 
Co-localization of m6A methyltransferase components and RNA Polymerase II (Pol II) at sites of 
transcription on Drosophila polytene chromosomes suggests that m6A methylation occurs whilst 
pre-mRNA is being transcribed [19]. The presence of m6A then influences subsequent events in 
mRNA processing and function in several ways (see below, Figure 1). These include effects on 
alternative pre-mRNA splicing, 3’-end processing, nuclear export, translation and mRNA decay 
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[6]. Other possible functions not yet explored might include transcriptional regulation and 
control of RNA localization. 
Pre-mRNA splicing: In mammals, components of the methyltransferase complex localize to 
speckles, where splicing occurs [44-46]. Since m6A is found in introns and affects alternative 
splicing of Sxl pre-mRNA, installation of m6A epimarks must occur co-transcriptionally and 
before splicing (Figure 1) [12, 19].  
Likewise m6A now has proven roles in regulation of alternative splicing, but it seems not 
to have a role in localizing splice sites in large introns [19, 32, 47]. For instance, m6A present in 
alternative exons induces their inclusion by directly recruiting the m6A-binding reader YTHDC1 
[48]. YTHDC1 then recruits the splicing factor SRSF3, promoting exon inclusion, and restricts 
binding of the exon-skipping factor SRSF10 [48].  
Lack of m6A in Drosophila mRNAs changes alternative splicing in ~2% of genes, with a 
strong preference (75%) for alternative splicing in 5’UTRs. Here, m6A directed alternative 
splicing regulation decreases the number of upstream AUGs in 5’UTRs, suggesting that m6A-
regulated alternative splicing increases translational of the main ORF [19, 32]. The 
experimentally measured m6A levels after a guanosine in Drosophila mRNAs are low [19], but it 
remains uncertain whether m6A in Drosophila is preferentially in an AAC context, or might 
initially be incorporated but then be removed – either by uncharacterized demethylases (see 
below) or in excised and rapidly degraded introns.  
In Sxl pre-mRNA in Drosophila, m6A is present in introns on either side of the male-
specific alternatively spliced exon that encodes a premature stop codon [19].  This makes 
expression of Sxl female-specific, so that sex determination can occur. To fully exclude this exon 
in females, Sxl binds on either side in the intron, in the vicinity of the m6A sites, and requires 
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assistance from the m6A reader YT521-B for full suppression of exon inclusion to achieve 
maximum Sxl expression. Besides its role in sex determination, Sxl has a second function in 
dosage compensation. Here, Sxl is required for very tight translational suppression of msl-2 in 
females. In males, Msl-2 directs up-regulation of transcription from the single X chromosome to 
neutralize the unequal numbers of X chromosomes between males and females [19]. The 
presence of a trace of Msl-2 in females will trigger dosage compensation and compromise 
viability. Hence, presence of m6A in the Sxl intron ensures by enhancing splicing that the 
maximum amount of Sxl is made to prevent ectopic dosage compensation in females. 
The N6-methyl group in adenosine weakens base-pairing, which can alter RNA structure 
[49]. Such structural changes, also termed m6A switch, have been associated with increased 
binding of hnRNPC and hnRNPG, and concomitant changes in alternative splicing [50, 51]. 
Whether m6A binding by the YTH domain proteins participate in this regulation, however, 
remains to be determined. 
3’-end processing: Knockout of METTL3 altered polyA site selection, indicating a role for m6A 
in alternative polyadenylation [52, 53]. Removal of m6A in human A549 cells switched polyA 
site choice towards the use of proximal polyA sites in a subset of transcripts resulting in 
shortened 3’UTRs [52]. Shorter UTRs are generally associated with higher levels of protein 
expression and cellular proliferation, while longer UTRs are more prevalent in differentiated 
cells such as neurons. In human embryonic stem cells and the B-cell lymphoblastoid cell line 
GM12878, presence of m6A in the last exon was associated with the use of proximal polyA sites 
suggesting cell type specific differences in the interpretation of m6A epimarks [53]. 
Nuclear export: Loss of the ALKBH5 eraser increases m6A in mRNA and results in more 
mRNA in the cytoplasm, suggesting that m6A-containing mRNAs are more readily exported 
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from the nucleus [54]. Lack of m6A also resulted in delayed appearance of clock gene transcripts 
in the cytoplasm resulting in an extension of the daily period [25]. Moreover, m6A is required for 
nuclear export of HIV-1 transcripts [55, 56]. 
Regulation of translation: An early observation was that the presence of m6A stimulated the 
translation of mouse dihydrofolate reductase mRNA using an in vitro rabbit reticulocyte 
translation system [57]. Consistent with a more general role in regulating translation, m6A is 
enriched in ribosome-associated mRNAs of several species [17-19]. The stimulatory effect on 
translation in mammals is mediated by binding of YTHDF1 to m6A near the stop codon, which 
then interacts with the translation initiation factor eIF3 [18]. In S. cerevisiae, IME4, and the m6A 
it introduces, is only present during meiosis, when its function is in remodelling of the 
translatome [17]. Also, METTL3 in mammals can stimulate translation in the cytoplasm, 
independently of its catalytic domain and m6A readers, by interacting with the translation 
machinery via its N-terminal domain [58]. During HIV-1 infection of cells, m6A and its YTDF 
readers have also been shown to enhance translation and viral replication [55, 56, 59]. 
A different role for m6A in regulating translation is indicated during Xenopus oocyte 
maturation [60]. Here, m6A methylated mRNAs are translated less, but m6A does not impact on 
mRNA stability. This suggests that the role of m6A in regulating translation may vary depending 
on cell type and developmental status. 
Another mechanism for the regulation of translation by m6A comes into play during 
stress responses (e.g. to UV or heat shock). Here, preferential m6A methylation of the 5’UTR of 
stress response genes leads to cap-independent translation, which involves nuclear re-localization 
of YTHDF2 to prevent m6A removal by the Fat-mass and obesity (FTO) demethylase [61, 62]. 
FTO has been shown to act primarily on N6-methyladenosine that is introduced at the first 
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position after the cap by a currently unknown methyltransferase and shows preference for m6A 
that is also 2’-O-methylated  (m6Am) [63]. 
mRNA decay: m6A has also been implicated in regulating mRNA decay. When transcription was 
halted with actinomycin D in cells lacking m6A writer the decay of many mRNAs was slowed 
[27, 64-66]. In contrast, 80% inhibition of m6A methylation by an S-adenosylhomocysteine 
analogue in HeLa delayed appearance of pulse-labelled mRNA in the cytoplasm, probably due to 
mRNA processing or export defects, but did not change the average half-life of all mRNAs [67].  
 In mouse embryonic stem (ES) cells m6A targets transcripts mediating pluripotency and 
lineage commitment for degradation [23, 26]. In addition, the reader YTHDF2 is required for 
clearance of maternal mRNA at the MZT early in zebrafish embryonic development [42]. These 
observations argue that m6A has a role in promoting mRNA decay, but this function might be 
restricted to certain cell types such as ES cells or to specific developmental transitions. A 
mutational analysis of m6A in labile transcripts would be required to determine whether m6A 
does indeed target transcripts for degradation. 
In mammals, the YTH domain-containing protein YTHDF2 recognizes m6A through its 
YTH C-terminal domain and directs mRNA to cytoplasmic P-bodies by recruiting the CCR4-
NOT deadenylase complex, initiating deadenylation and degradation of methylated transcripts 
[65, 68]. Recently, YTHDF3, another cytoplasmic protein, was shown to interact co-operatively 
with YTHDF2 to accelerate mRNA decay [66]. YTHDF3 in co-operation with a third YTH 
protein, YTHDF1 also promotes translation of methylated RNAs [66, 69]. It is not yet clear how 
these different interactions between YTH proteins occur and what controls their selectivity 
towards m6A sites. This is likely to depend on sequence context and may be dynamically 
regulated.  
 12 
miRNA processing: Processing of pri-miRNAs has been shown to require m6A-facilitated 
binding of DGCR8, which is important for recruitment of DROSHA for nuclear pri-miRNA 
cleavage. Promoting miRNA processing further requires binding of hnRNPA2B1 to m6A in pri-
miRNAs [70, 71].  
Long non-coding RNAs: A role for m6A has been revealed in the long non-coding RNA Xist, 
which is required for dosage compensation in humans. Here, m6A in Xist RNA promotes 
heterochromatinization to transcriptionally inactivate one of the X chromosomes [28]. 
In summary, the role of m6A in enhancing alternative splicing, stimulation of nuclear 
export of mRNAs and translation suggest a broad function in boosting gene expression from pre-
set regulation. In addition, m6A appears to have a second function in promoting removal and 
perhaps translational silencing of m6A marked transcripts to facilitate developmental transitions 
as in oocyte development upon commencement of meiosis, in maternal to zygotic transition in 
early embryogenesis and from stem cell renewal to the initiation of differentiation. All together, 
these examples suggest a key role for m6A in fine-tuning gene expression. 
 
Tweaking the output: Analogy to miRNA regulation, but mostly to get more?  
A role for m6A in fine-tuning gene expression post-transcriptionally is reminiscent of the role of 
miRNAs in this process. A fundamental feature of miRNA regulation, however, is down- 
regulation of gene expression. miRNAs bound by Argonaute proteins affect mRNA stability by 
directing mRNA cleavage or by inhibiting translation; and there are only a few exceptions to this 
rule [72-75]. 
It may therefore be reasonable to suggest that cells contain a mechanism to balance the 
action of miRNA regulation for buffering fluctuations in gene expression by up-regulating 
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translation (Figure 2). Such a role of m6A to boost gene expression makes biological sense for 
cells that need to react quickly to developmental signals during cellular differentiation, but also 
to adapt to environmental changes by altering metabolism.  
Meiosis in yeast is induced by starvation. Although starvation stress generally reduces 
gene expression, meiotic transcripts evade this response by being m6A methylated, which in turn 
enhances their translation [17]. A role for m6A in up-regulating translation has also been found in 
dihydrofolate reductase and p21 transcripts [57, 76]. Likewise, a more general role of m6A in 
enhancing translation is indicated from enrichment of m6A on translating ribosomes and a direct 
interaction of the m6A reader YTHDF1 with the translation initiation factor eIF3 [17-19]. 
Consistent with such a role, viruses such as HIV-1 have exploited this route to enhance 
production of viral proteins to be ahead of the host response [55, 56, 59]. 
A further role for m6A in promoting translation has been revealed during heat-shock 
stress. Under such conditions of general shut down-of gene expression, m6A in the 5’UTR can 
direct selective translation of transcripts after de-capping [61, 62]. UV-light induced DNA 
damage also relies on m6A, but whether this involves enhanced translation e.g. of DNA repair 
enzymes needs to be elaborated [77]. 
A different role in enhancing protein production has been assigned to N6-
methyladenosine when in the cap adjacent position. Here, m6A and m6Am directly counteract 
miRNA mediated de-capping [63]. 
Another mechanism for making more protein has been revealed in the Drosophila sex 
determination pathway where the amount of female-specific Sxl is most critical for fully 
suppressing dosage compensation. Here, m6A in the introns flanking an alternatively spliced 
exon is required to enhance skipping of this exon, whose inclusion results in a truncated non-
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functional Sxl protein. In fact, m6A present in alternative exons has also been shown to enhance 
their inclusion likely resulting in higher protein levels of longer isoforms [48]. 
In human dosage compensation, m6A enhances the function of the non-coding RNA Xist 
in inactivating one of the X chromosomes in females. The exact mechanism how m6A in Xist 
drives condensation of the chromatin of this X chromosome, however, is not known [28]. 
In support of such a ubiquitous role of m6A in adjusting gene expression, we find 
methyltransferase complex components associated with most if not all RNA Pol II transcribed 
genes in Drosophila [19]. Since Drosophila is weakly viable without m6A, this suggests that 
m6A is mostly used for non-vital aspects of gene expression to increase fitness and adaptability. 
Since many miRNA mutants also display very mild phenotypes (reviewed in [75]) a main role 
for m6A in Drosophila to counteract miRNA regulation appears possible.  
The presence of demethylases remains to be demonstrated in Drosophila, but they could 
be absent. In addition, it is also not clear whether m6A affects mRNA stability and pri-miRNA 
processing in Drosophila.  
Functional antagonism between m6A and miRNAs is further suggested from Argonaute 
binding sites which overlap with m6A sites in mRNA 3’UTR of mouse brains [44]. However, 
there are likely exceptions to a simple model whereby m6A’s main role is in enhancing gene 
expression to counteract miRNAs. Notably, mammals have expanded m6A regulation to vital 
processes and also increased the number of YTH reader proteins compared to Drosophila. 
Likewise, m6A is required for efficient processing of pri-miRNA and thus m6A supports miRNA 
mediated down-regulation of gene expression. Further regulatory interplay is indicated from 
miRNAs that impact on m6A levels in transcripts of YTH domain proteins to affect their 
translation [52, 78, 79]. Likewise, m6A has also been shown to enhance mRNA decay in some 
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cell types [27, 42, 64-66]. In zebrafish, m6A is further assisted by miR-430 in clearance of 
maternal transcripts at the MZT [42]. 
It remains to be determined, however, whether m6A is differentially recognized by YTH 
domain proteins for transcript-specific fates in different cell-types or whether m6A is used in a 
cell type-specific manner to either direct translational enhancement or mRNA decay. Potentially, 
transcript specific outcomes could be generated through interaction of YTH proteins with other 
RNA binding proteins such as Sxl or related ELAV/Hu family proteins [12, 19, 80]. 
In addition, demethylases can remove m6A epimarks, but this is not simply a cytoplasmic 
pathway to remove nuclear installed m6A as ALKBH5 localizes to nuclear speckles and FTO 
shuttles between the nucleus and the cytoplasm [54, 63]. 
 
Concluding Remarks 
The novel field of epitranscriptomics has yielded fundamental progress in defining the topology 
of mRNA modifications genome-wide – and especially of m6A, the most abundant modification. 
Further technological advances will be needed before we can measure low and dynamic changes 
in m6A [81], maybe by harnessing new sequencing technologies that allow the determination of 
mRNA modifications in single molecules. 
Now, biological functions for this enigmatic m6A modification are emerging through more 
mechanistic analysis revealing an ancient mechanism to fine-tune gene expression.  
Much remains to be learned before we can understand how the dynamic regulation of the co-
transcriptional installation of m6A methyl marks is dynamically instructed, how m6A impacts on 
downstream mRNA processing events and how its mis-regulation results in human disease (See 
Outstanding Questions). 
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Outstanding question box 
- Is m6A introduced co-transcriptionally, and if so by what mechanism? 
- How are putative m6A methylation sites recognized, and why are only some of them 
methylated? 
- How is the emplacement of an m6A epimark regulated? 
- How is m6A recognized, in various contexts, by the various reader proteins? 
- Does m6A modification target individual mRNAs to specific fates – for example, to be 
translated faster or to be degraded? 
- Does m6A have a role in dosage compensation in organisms other than humans and 
Drosophila? 
 
 
Box 1: Epitranscriptomics (greek “epi”: on top of) 
Modification of nucleotides in mRNA adds additional information that is not encoded in the 
mRNA or DNA sequence. The novel field of epitranscriptomics examines where modified 
nucleotides are present in mRNA, how they are emplaced, read and removed (by ‘writers’, 
‘readers’ and ‘erasers’) and how they may modulate mRNA structure [82] (see Box 2). Methyl 
epimarks are metabolically dynamic, suggesting a highly regulated process. It is possible that 
modified nucleotides in mRNA might be inherited epigenetically – e.g. in RNA viruses or from 
the mother – but no such mechanism has yet been found.  
 
Box 2: The m6A writers, readers and erasers. 
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Writers: Methylation of A bases to m6A in mRNAs is catalysed by a methyltransferase complex 
that includes the catalytic subunit METhylTransferase Like 3 (METTL3, also called MT-A70, 
MTA or IME4), METhylTransferase Like 14 (METTL14), which seems to be catalytically 
inactive, Wilms Tumor 1 Associated Protein (WTAP, also called Fl(2)d), KIAA1429 (also 
called Virilizer) and RNA Binding Motif 15 (RBM15, also called Spenito) [19, 22, 27, 32, 46, 
64, 83-87]. Core m6A methyltransferase complex components (METTL3, and METTL14, 
WTAP and Vir) are highly conserved in most eukaryotes, but are absent from the fission yeast S. 
pombe and the nematode C. elegans [88, 89], suggesting that m6A on mRNA is not present in 
these organisms. 
Readers: YTH domain-containing proteins have recently been identified as readers of m6A 
marks on mRNA.  They display a 10-50-fold higher affinity for m6A methylated mRNA than for 
unmethylated mRNA [19, 90-93]. Animals have two families of YTH proteins. One has two 
members in humans (YTHDC1 and YTHDC2) and one in Drosophila (YT521-B), and the other 
has three members in humans (YTHDF1/2/3) and one in Drosophila (CG6422). Plants have 
many more (13 in Arabidopsis) [88]. In the nematode C. elegans, YTH proteins are also absent 
[88]. 
Erasers: m6A can be reverted to adenosine by the m6A RNA demethylase ALKBH5 in 
mammals, but whether demethylases exist in lower eukaryotes remains to be determined [54]. A 
second demethylase from mammals, Fat Mass and Obesity-associated protein (FTO) was 
initially thought to play a similar function, but a recent report suggests that its in vivo activity is 
rather dedicated towards the methylation present when the first cap adjacent nucleotide is an 
adenosine. The enzyme placing this m6A modification is not yet known [54, 63, 94, 95].  
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Box 3: Dosage compensation 
Dosage compensation describes the adjustment of gene expression for the unequal numbers of 
sex chromosomes in males and females: Aneuploidy of sex chromosomes would otherwise be 
lethal. Different organisms use a variety of mechanisms both for sex determination and for 
dosage compensation. In humans, one female X chromosome is inactivated; in Drosophila, the 
male X chromosome is up-regulated to transcribe twice as much; and in Caenorhabditis, both X 
chromosomes in hermaphrodites are down-regulated [19, 28]. 
 
Glossary 
(see Box 2, main text for additional explanations of gene and protein functions) 
 
3’-UTR (3’-untranslated region) 
region of the mRNA after the stop codon of the coding sequence 
 
5’-UTR (5’-untranslated region) 
region of the mRNA before the start codon of the coding sequence 
 
ALKBH5 (ALKB Homolog 5) 
m6A mRNA demethylase that removes the methyl group associated with N6-methyladenosine 
 
CCR4-NOT complex 
conserved multi-subunit complex involved in mRNA deadenylation 
 
DGCR8 
subunit of the microprocessor complex that mediates the biogenesis of miRNA from the primary 
microRNA transcript 
 
DSR (Determinant of selective removal) 
cis-regulatory element that targets yeast meiotic specific mRNA for decay by the exosome via 
Mmi1 recruitment 
 
FTO (Fat mass and obesity associated protein) 
m6A mRNA demethylase that removes the methyl group of N6-methyladenosine present at the 
first position after the cap 
 
HIV-1 (Human Immunodeficiency virus) 
Lentivirus (subclass of retrovirus) that causes the acquired immunodeficiency syndrome (AIDS) 
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hnRNP C (heterogeneous nuclear Ribonucleoprotein C) 
RNA binding protein that binds m6A-containing RNA due to changes in local structure of the 
mRNA induced by m6A  
 
IME4 (Inducer of Meiosis-4) 
component of the methyltransferase complex, also named METTL3 
 
m6A-switch 
alteration of the local structure of the mRNA induced by m6A 
 
Mmi1 
YTH domain-containing protein, which lost its ability to recognize m6A and directs yeast meiotic 
mRNAs to degradation via binding to the DRS. 
 
METTL3 (Methyltransferase like 3) 
methyltransferase involved in m6A deposition on mRNA, also named MTA-70, MTA and IME4.  
 
METTL14 (Methyltransferase like 14) 
component of the m6A methyltransferase complex that serves as a support protein for METTL3, 
but seems catalytically inactive. 
 
RBM15 (RNA Binding Motif Protein 15) 
Member of the Split-end family of protein and component of the m6A methyltransferase complex 
that recruits the methylosome to its target mRNAs 
 
Sxl (Sex lethal) 
master regulator of the sex determination and dosage compensation pathways in Drosophila.  
 
SRSF3 (Serine and Argine Rich Splicing Factor 3) 
splicing factor recruited to pre-mRNA near m6A sites via the m6A reader YTHDC1, resulting in 
exon inclusion 
 
SRSF10 (Serine and Arginine Rich Splicing Factor 10) 
Splicing factor that interacts with the m6A reader YTHDC1, preventing its binding to mRNA 
close to m6A-containing regions, leading to exon skipping. 
 
WTAP (Wilms Tumor 1 Associated Protein) 
subunit of the methyltransferase complex that stabilizes the integrity of the heterodimer 
METTL3/METTL14. 
 
YTH proteins 
Class of proteins that specifically recognize m6A in mRNA 
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Figure legends 
 
Figure 1. The writers, readers and erasers of m6A.  
The m6A writer complex is composed of at least five proteins, including the catalytic subunit 
METTL3. METTL14 serves as structural support for METTL3, while WTAP stabilizes the core 
complex. RBM15 helps in recruiting the complex to its target sites. The molecular function of 
Virilizer is currently unknown.  
Co-localization of m6A writers with RNA Pol II on Drosophila polytene chromosomes 
suggests co-transcriptional installation of m6A epimarks [19]. ALKBH5 and FTO are two 
demethylases that remove the methyl group from m6A and m6Am (2’-O-ribosemethylated m6A), 
respectively. m6A readers include hnRNPA2B1 and members of the YTH-domain family of 
proteins. These factors mediate the function of m6A in several processes including X-
chromosome inactivation, pre-mRNA splicing and 3’end processing, mRNA export, translation 
and mRNA decay. Other possible functions not yet explored might include transcriptional 
regulation and RNA localization. 
 
Figure 2: Roles of m6A in regulating gene expression. 
Model that depicts opposing roles of m6A and miRNA in fine-tuning gene expression during 
normal mammalian development and adult homeostasis. While miRNA mainly down-regulates 
gene expression m6A in contrast maximizes it (black arrows).  
However, at specific developmental transitions or/and cell types m6A can also reduce 
gene expression (dashed arrow).  Likewise, in very few cases, miRNA was shown to increase 
gene expression (thin dash arrow). m6A can also directly facilitate miRNA biogenesis, whereas a 
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specific miRNA was shown to influence m6A levels via regulation of the m6A reader YTHDF2 
(double dashed arrow). The situation in Drosophila is similar but less complex (see main text).  
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